Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mary Ann Gray currently holds 4,956 shares of JUNIPER PHARMACEUTICALS INC (JNP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mary Ann Gray has been a net seller of JNP stock. They have purchased $48.2K and sold $847.8K worth of shares.
Mary Ann Gray's most recent insider trade was on Jan 30, 2026, when they sold 4,956 shares at $0.00 per share.
Mary Ann Gray serves as Executive at JUNIPER PHARMACEUTICALS INC (JNP). They have executed 53 insider transactions totaling $896.0K over their tenure at the company.
Mary Ann Gray holds the position of Executive at JUNIPER PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Mary Ann Gray has shown a selling trading pattern, with $48.2K in total purchases and $847.8K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mary Ann Gray was on Jan 14, 2016, when they sold $874.3K worth of DYAX shares. This transaction involved 33,333 shares at $26.23 per share.
Mary Ann Gray currently owns 4,956 shares of JUNIPER PHARMACEUTICALS INC (JNP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mary Ann Gray's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mary Ann Gray has 53 Form 4 filings on record as an insider at JUNIPER PHARMACEUTICALS INC.
Set alerts for Mary Ann Gray and 40,000+ other insiders.